ArticleCureus2025
Chronic Kidney Disease as a Predictor of Mortality in Hospitalized Inflammatory Bowel Disease Patients With Clostridioides difficile Infection.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Clostridioides difficile infection (CDI) leads to significant morbidity and mortality in hospitalized patients. We aim to investigate whether chronic kidney disease (CKD) or end-stage renal disease (ESRD) are predictors of mortality in admitted patients with CDI, and whether the presence of inflammatory bowel disease (IBD) has any impact on the mortality rate. Methods The data of 133,099 hospitalized patients with CDI were analyzed from the National Inpatient Sample (NIS) database from 2016 to 2018. Baseline risk factors were identified using ICD-10 codes. Propensity score matching was used to match CKD/ESRD patients with patients without kidney disease based on age, gender, and IBD status (Crohn's disease or ulcerative colitis). A multivariable logistic regression model was used to establish the relationship between variables and adjusted for underlying risk factors. The primary endpoint was all-cause mortality among hospitalized patients with CDI, particularly those with IBD. Results Our cohort included 133,099 hospitalized patients with CDI, among whom 20,700 (15.6%) had CKD, 12,178 (9.1%) had ESRD, and 6104 (4.6%) had IBD. The mean age was 74, 63, and 63 years (p<0.001) in patients with CKD, ESRD, and those without kidney disease, respectively. CDI patients with ESRD had a higher proportion of males (6095, 50.3%), compared to those with CKD and without kidney disease (9494, 45.9%, and 40,876, 40.8%, respectively; p<0.001). Propensity score matching was performed, and the patients were matched on age, resulting in a 1:1 exact match for 32,878 patients. Logistic regression analysis showed that in CDI patients with IBD, CKD was associated with a statistically insignificant trend towards a higher all-cause mortality rate as compared to CDI patients without IBD (odds ratio, 1.682 vs odds ratio, 1.229, p>0.05). However, ESRD patients had a significantly higher all-cause mortality rate (Odds ratio, 3.738, 95% CI 2.175-6.425) among hospitalized CDI patients with IBD compared to those without IBD (odds ratio, 1.612, 95% CI 1.486-1.749) (p<0.05). Conclusion Kidney disease, particularly ESRD, is associated with a significant increase in mortality in CDI patients with IBD compared to those without IBD. These findings highlight the importance of aggressive CDI management in patients with IBD and ESRD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.